MedTrace Logo

Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy

NCT05852132 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 249

Last updated 2024-03-15

No results posted yet for this study

Summary

To investigate the prognosis of retinal structure and function after vitrectomy in patients with severe non-proliferative diabetic retinopathy, to explore the feasibility of vitrectomy in patients with severe non-proliferative diabetic retinopathy(NPDR), and to seek the best way to delay the progression of diabetic retinopathy from the perspective of therapeutic effect.

Conditions

  • Non Proliferative Diabetic Retinopathy(NPDR)

Interventions

PROCEDURE

pars plana vitrectomy(PPV)

Vitrectomy was performed for severe non-proliferative diabetic retinopathy, but panretinal photocoagulation(PRP) was not performed

PROCEDURE

Pars plana vitrectomy(PPV) +Panretinal photocoagulation(PRP)

PPV was performed for severe non-proliferative diabetic retinopathy with PRP.

PROCEDURE

Panretinal photocoagulation(PRP)

Only PRP was used for severe non-proliferative diabetic retinopathy.

Sponsors & Collaborators

  • Fei Gao

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-05
Primary Completion
2026-03-31
Completion
2026-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05852132 on ClinicalTrials.gov